Suppr超能文献

鼻内镜下经鼻入路联合同期经颅入路治疗巨大垂体瘤

Endoscopic Endonasal Approach Combined with a Simultaneous Transcranial Approach for Giant Pituitary Tumors.

作者信息

Kuga Daisuke, Toda Masahiro, Ozawa Hiroyuki, Ogawa Kaoru, Yoshida Kazunari

机构信息

Department of Neurosurgery, Keio University School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan.

Department of Neurosurgery, Keio University School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan.

出版信息

World Neurosurg. 2019 Jan;121:173-179. doi: 10.1016/j.wneu.2018.10.047. Epub 2018 Oct 16.

Abstract

BACKGROUND

The endoscopic endonasal approach is widely used for treating giant pituitary adenomas. However, a small subset of tumors is still challenging to treat, and the risk of complications increases when an endoscopic endonasal approach alone is used. The simultaneous combined endoscopic endonasal and transcranial approach is a surgical option for such difficult adenomas; however, very few studies have described the technical nuances and benefits of this approach.

METHODS

We treated 3 patients with giant pituitary adenoma and 1 patient with pituicytoma. Radiologic findings and clinical outcomes were retrospectively reviewed.

RESULTS

All patients had preoperative visual disturbances. A pterional approach was combined with an endoscopic endonasal approach to treat all the patients. Near-total and subtotal tumor removal was accomplished in 3 patients; however, only partial tumor removal was possible in 1 patient. Postoperative visual function improved in 3 patients, but there were no changes in 1 patient. There were no major complications; however, each patient developed either adrenocorticotropic hormone (ACTH) and thyroid-stimulating hormone deficiency or ACTH deficiency and persistent diabetes. Importantly, no cerebrospinal fluid leakage was observed in the patients.

CONCLUSIONS

Our simultaneous combined endoscopic and transcranial approach offers safe tumor resection and a low rate of complications. In this procedure, it is important that tumor debulking be performed by the main surgeon via a single surgical route and not by 2 surgeons using the simultaneous endonasal and transcranial approach, to avoid interference in the surgical field. This approach may be considered as a surgical option for carefully selected tumors in the sellar region.

摘要

背景

鼻内镜下经鼻入路广泛应用于巨大垂体腺瘤的治疗。然而,仍有一小部分肿瘤的治疗具有挑战性,单独采用鼻内镜下经鼻入路时并发症风险会增加。鼻内镜下经鼻与经颅联合入路是治疗此类困难腺瘤的一种手术选择;然而,很少有研究描述这种入路的技术细节和优势。

方法

我们治疗了3例巨大垂体腺瘤患者和1例垂体细胞瘤患者。对影像学检查结果和临床结局进行了回顾性分析。

结果

所有患者术前均有视力障碍。所有患者均采用翼点入路联合鼻内镜下经鼻入路进行治疗。3例患者实现了近全切除和次全切除;然而,1例患者仅能进行部分肿瘤切除。3例患者术后视力功能改善,但1例患者无变化。无严重并发症;然而,每位患者均出现促肾上腺皮质激素(ACTH)和促甲状腺激素缺乏或ACTH缺乏及持续性糖尿病。重要的是,患者未观察到脑脊液漏。

结论

我们的鼻内镜与经颅联合入路提供了安全的肿瘤切除和低并发症发生率。在该手术中,重要的是由主刀医生通过单一手术路径进行肿瘤减容,而不是由两名医生同时采用经鼻和经颅入路,以避免干扰手术视野。对于精心挑选的鞍区肿瘤,这种入路可被视为一种手术选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验